Eversana Reveals new Market Access Portfolio

Published on: 

Pharmaceutical Executive

Eversana, an independent provider of global services to the life sciences industry, annouced Health Strategies Insights by Eversana, a market access research and insights portfolio to help life sciences innovators make more informed decisions throughout the product lifecycle.

“The evolution of our market intelligence capabilities strengthens Eversana's growing life science platform,” said Rod Cavin, General Manager for Health Strategies Insights by Eversana. “The product portfolio provides valuable market access insights to leading global biopharmaceutical companies in various phases of product development across a number of therapeutic areas-helping our clients achieve commercial success.”